Fig. 5.

Infection of BALB/c mice is inhibited by PAR2 activating peptide. Experiments were conducted as in Fig. 1 using BALB/c mice to investigate the simultaneous injection of TF competent HSV1 (grey bar, from Fig. 1A, Virus, TF+) with PAR2ap (3 umol/kg, n=7). In all panels data are expressed as mean ± SEM. As determined by Student’s t test, **P ≤ 0.05 and *P ≤ 0.10 compared to no addition of PAR2ap.